Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,042 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct191 mentions
- AI agenttechnology188 mentions
- Anthropicorganization177 mentions
- ChatGPTproduct177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
U.S. Food and Drug Administration
organization320 mentionslast seen Nov 13, 2026
The regulatory agency that approved Mint and received the 510(k) application for 3D Intelligence.
Relationships 50+
- U.S. Food and Drug Administrationapprovespelareorep99% confidence4 sources
- U.S. Food and Drug AdministrationapprovesZYNLONTA99% confidence3 sources
- U.S. Food and Drug AdministrationapprovesATR-0499% confidence3 sources
- U.S. Food and Drug AdministrationapprovesRASONQUE99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesFAYUVI99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesEmboliner Embolic Protection System99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesAmtagvi99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesBEA-1799% confidence2 sources
- U.S. Food and Drug AdministrationapprovesARAKODA99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesGENGLYCOS99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesUPTUNITY™ | Aneurysm99% confidence2 sources
- U.S. Food and Drug Administrationapprovesneflamapimod99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesJaypirca99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesISEMBYLD99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesLibervant99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesWellPD99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesAmeluz99% confidence1 source
- U.S. Food and Drug AdministrationapprovesTLANDO99% confidence1 source
- U.S. Food and Drug AdministrationapprovesEMCITATE99% confidence1 source
- U.S. Food and Drug AdministrationapprovesMint99% confidence1 source
- U.S. Food and Drug AdministrationapprovesBoneEnhance99% confidence1 source
- U.S. Food and Drug AdministrationapprovesNXC-20199% confidence2 sources
- U.S. Food and Drug AdministrationapprovesMOGENRY98% confidence3 sources
- U.S. Food and Drug AdministrationapprovesRevita DMR System98% confidence2 sources
- U.S. Food and Drug AdministrationapprovesRingConn Smart Ring98% confidence1 source
- U.S. Food and Drug AdministrationapprovesRASONQUE98% confidence1 source
- U.S. Food and Drug AdministrationapprovesCGuard Prime TransCarotid Stent System98% confidence1 source
- U.S. Food and Drug AdministrationapprovesCGuard Prime for TCAR98% confidence1 source
- U.S. Food and Drug AdministrationapprovesM•care System98% confidence1 source
- U.S. Food and Drug AdministrationapprovesSynergy Disc98% confidence1 source
- U.S. Food and Drug AdministrationapprovesKeramatrix98% confidence1 source
- U.S. Food and Drug AdministrationapprovesAptiva Antiphospholipid Syndrome IgA Reagent98% confidence1 source
- U.S. Food and Drug AdministrationapprovesHēlo Thrombectomy System98% confidence1 source
- U.S. Food and Drug AdministrationapprovesAVMAPKI FAKZYNJA CO-PACK98% confidence1 source
- U.S. Food and Drug AdministrationapprovesAI4Eyes eye care platform98% confidence1 source
- U.S. Food and Drug AdministrationapprovesSetPoint System98% confidence1 source
- U.S. Food and Drug AdministrationapprovesAI Highlights98% confidence1 source
- U.S. Food and Drug AdministrationapprovesGammaTile98% confidence1 source
- U.S. Food and Drug AdministrationapprovesVOCERYQ98% confidence1 source
- U.S. Food and Drug Administrationapprovesinebilizumab98% confidence1 source
- U.S. Food and Drug AdministrationapprovesAtebrioz98% confidence1 source
- U.S. Food and Drug AdministrationapprovesSwiftSight Body Composition98% confidence1 source
- U.S. Food and Drug AdministrationapprovesLiora Monofilament Scaffold98% confidence1 source
- U.S. Food and Drug AdministrationapprovesTumorSight Risk98% confidence1 source
- U.S. Food and Drug AdministrationapprovesCORE 30098% confidence1 source
- U.S. Food and Drug AdministrationapprovesHēlo Return98% confidence1 source
- U.S. Food and Drug AdministrationapprovesOnswik98% confidence1 source
- U.S. Food and Drug AdministrationapprovesTelomir-Zn98% confidence1 source
- U.S. Food and Drug AdministrationapprovesNuance Audio Plus98% confidence1 source
- U.S. Food and Drug AdministrationapprovesEntolimod97% confidence2 sources
Relationship
U.S. Food and Drug AdministrationapprovesMOGENRY
98% confidence3 supporting mentions
Either name opens that entity’s relationships.
Sources 3
- newsPR NewswireNov 5, 2026Nanoscope Therapeutics Appoints Ophthalmology and Rare Disease Regulatory Leader Damon Daulerio as Executive Director of Regulatory Affairs
the FDA has accepted for review the company's Biologics License Application (BLA) for MOGENRY
- newsPR NewswireOct 14, 2026Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain
the FDA has accepted and filed the company's Biologics License Application (BLA) for MOGENRY
- newsPR NewswireOct 6, 2026Nanoscope Therapeutics to Participate in Eyecelerator 2026 and the American Academy of Ophthalmology 2026 Annual Meeting
MOGENRY is under review by the FDA